VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma

We retrospectively reviewed outcomes of treatment with VIP (combination of etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma (STS). We analyzed the medical records of patients with advanced or relapsed STS who had undergone VIP treatment as second-line or...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Main Authors: Moon, Ji Young, Baek, Seung-Woo, Ryu, Hyewon, Choi, Yoon-Seok, Song, Ik-Chan, Yun, Hwan-Jung, Jo, Deog-Yeon, Kim, Samyong, Lee, Hyo Jin
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
5700
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5287961/
https://ncbi.nlm.nih.gov/pubmed/28121937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005942
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares